Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.87 |
---|---|
High | 20.16 |
Low | 19.43 |
Bid | 19.98 |
Offer | 20.11 |
Previous close | 19.74 |
Average volume | 10.01m |
---|---|
Shares outstanding | 233.08m |
Free float | 222.18m |
P/E (TTM) | 142.10 |
Market cap | 4.66bn USD |
EPS (TTM) | 0.1406 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- ADMA Biologics Set to Join S&P SmallCap 600 Index
- ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
- ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
- ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
- ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
- ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
- ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
- ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
- ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
- ADMA Biologics Announces CFO Transition
More ▼